Hybrid coronary revascularization: Promising, but yet to take off

Journal of the American College of Cardiology

Volumn 65, Issue 1, 2015, Pages 85-97

  Panoulas, Vasileios F ^a,b,c   Colombo, Antonio ^a,b   Margonato, Alberto ^a   Maisano, Francesco ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

artery bypass; artery revascularization; Coronary artery bypass; coronary intervention; direct coronary; graft surgery; grafting percutaneous; hybrid coronary; minimally invasive

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT;

ARTICLE; BARE METAL STENT; BLEEDING; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; HYBRID CORONARY REVASCULARIZATION; IN-STENT RESTENOSIS; INTERNAL MAMMARY ARTERY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MORTALITY; PACLITAXEL ELUTING STENT; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; SINGLE DRUG DOSE; SIROLIMUS ELUTING STENT; STENT THROMBOSIS; SURVIVAL; THROMBOSIS; VEIN GRAFT; ZOTAROLIMUS ELUTING STENT; PROCEDURES;

DRUG-ELUTING STENTS; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS;

EID: 84920545115     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.093     Document Type: Review

References (61)

1. G.D. Angelini, P. Wilde, T.A. Salerno, G. Bosco, and A.M. Calafiore Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation Lancet 347 1996 757 758
2. C.T. Lloyd, A.M. Calafiore, and P. Wilde Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization Ann Thorac Surg 68 1999 908 911
3. R.E. Harskamp, J.O. Bonatti, and D.X. Zhao Standardizing definitions for hybrid coronary revascularization J Thorac Cardiovasc Surg 147 2014 556 560
4. CASS Principal Investigators and Their Associates Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data Circulation 68 1983 939 950
5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
6. BARI Investigators The final 10-year follow-up results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
7. E.P. Navarese, K. Tandjung, and B. Claessen Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis BMJ 347 2013 f6530
8. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
9. F. Otsuka, K. Yahagi, K. Sakakura, and R. Virmani Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg 2 2013 519 526
10. J. Tatoulis, B.F. Buxton, and J.A. Fuller Patencies of 2127 arterial to coronary conduits over 15 years Ann Thorac Surg 77 2004 93 101
11. P.A. Hayward, and B.F. Buxton Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits Ann Thorac Surg 84 2007 795 799
12. J.H. Alexander, G. Hafley, and R.A. Harrington Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
13. J.D. Puskas, W.H. Williams, and E.M. Mahoney Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial JAMA 291 2004 1841 1849
14. J.F. Sabik III, B.W. Lytle, E.H. Blackstone, P.L. Houghtaling, and D.M. Cosgrove Comparison of saphenous vein and internal thoracic artery graft patency by coronary system Ann Thorac Surg 79 2005 544 551
15. K.R. Cho, D.S. Jeong, and K.B. Kim Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery Eur J Cardiothorac Surg 32 2007 718 723
16. N.D. Desai, C.D. Naylor, and A. Kiss Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial Circulation 115 2007 684 691
17. K.B. Kim, K.R. Cho, and D.S. Jeong Midterm angiographic follow-up after off-pump coronary artery bypass: serial comparison using early, 1-year, and 5-year postoperative angiograms J Thorac Cardiovasc Surg 135 2008 300 307
18. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913
19. D. Carrie, J. Berland, and S. Verheye A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions J Am Coll Cardiol 59 2012 1371 1376
20. G.G. Stefanini, P.W. Serruys, and S. Silber The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention) J Am Coll Cardiol 57 2011 2221 2232
21. F.W. Mohr, M.C. Morice, and A.P. Kappetein Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Lancet 381 2013 629 638
22. V. Farooq, P.W. Serruys, and Y. Zhang Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX Trial at 5 years: Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial J Am Coll Cardiol 62 2013 2360 2369
23. S.J. Head, S. Kaul, and M.J. Mack The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease Eur Heart J 34 2013 2510 2518
24. G. Sianos, M.A. Morel, and A.P. Kappetein The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
25. A.J. Rastan, T. Walther, and V. Falk Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 120 (Suppl 11) 2009 S70 S77
26. J. Bonatti, E. Lehr, M.R. Vesely, G. Friedrich, N. Bonaros, and D. Zimrin Hybrid coronary revascularization: which patients? When? How? Curr Opin Cardiol 25 2010 568 574
27. L.D. Hillis, P.K. Smith, and J.L. Anderson 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e123 e210
28. S. Windecker, P. Kolh, and F. Alfonso 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) EuroIntervention 2014 Sep 3 [E-pub ahead of print]
29. R.E. Harskamp, J.M. Brennan, and Y. Xian Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database Circulation 130 2014 872 879
30. Z.N. Kon, E.N. Brown, and R. Tran Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass J Thorac Cardiovasc Surg 135 2008 367 375
31. W.B. Bachinsky, M. Abdelsalam, G. Boga, L. Kiljanek, M. Mumtaz, and C. McCarty Comparative study of same sitting hybrid coronary artery revascularization versus off-pump coronary artery bypass in multivessel coronary artery disease J Interv Cardiol 25 2012 460 468
32. J.G. Byrne, M. Leacche, D.E. Vaughan, and D.X. Zhao Hybrid cardiovascular procedures J Am Coll Cardiol Intv 1 2008 459 468
33. M.E. Halkos, P.F. Walker, and T.A. Vassiliades Clinical and angiographic results after hybrid coronary revascularization Ann Thorac Surg 97 2014 484 490
34. M.E. Halkos, T.A. Vassiliades, and J.S. Douglas Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease Ann Thorac Surg 92 2011 1695 1701
35. J.O. Bonatti, D. Zimrin, and E.J. Lehr Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results Ann Thorac Surg 94 2012 1920 1926
36. L. Shen, S. Hu, and H. Wang One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution J Am Coll Cardiol 61 2013 2525 2533
37. C. Adams, D.J. Burns, and M.W. Chu Single-stage hybrid coronary revascularization with long-term follow-up Eur J Cardiothorac Surg 45 2014 438 442 discussion 442-3
38. B. Kiaii, R.S. McClure, and P. Stewart Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up J Thorac Cardiovasc Surg 136 2008 702 708
39. B. Reicher, R.S. Poston, and M.R. Mehra Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes Am Heart J 155 2008 661 667
40. D.X. Zhao, M. Leacche, and J.M. Balaguer Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization: results from a fully integrated hybrid catheterization laboratory/operating room J Am Coll Cardiol 53 2009 232 241
41. C. Patrono, F. Bachmann, and C. Baigent Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology Eur Heart J 25 2004 166 181
42. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913
43. A. Repossini, M. Tespili, and A. Saino Hybrid revascularization in multivessel coronary artery disease Eur J Cardiothorac Surg 44 2013 288 293
44. D.M. Holzhey, S. Jacobs, and M. Mochalski Minimally invasive hybrid coronary artery revascularization Ann Thorac Surg 86 2008 1856 1860
45. D.L. Bhatt, and R.A. Harrington Platelet inhibition with cangrelor during PCI N Engl J Med 369 2013 393 394
46. T.A. Vassiliades, P.D. Kilgo, and J.S. Douglas Clinical outcomes after hybrid coronary revascularization versus off-pump coronary artery bypass: a prospective evaluation Innovations (Phila) 4 2009 299 306
47. S. Srivastava, S. Gadasalli, and M. Agusala Beating heart totally endoscopic coronary artery bypass Ann Thorac Surg 89 2010 1873 1879
48. S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
49. J. Bennett, and C. Dubois A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease Biologics 7 2013 149 159
50. M. Valgimigli, G. Campo, and M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
51. A. Colombo, A. Chieffo, and A. Frasheri Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial J Am Coll Cardiol 64 2014 2086 2097
52. M. Haude, R. Erbel, and P. Erne Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial Lancet 381 2013 836 844
53. P.W. Serruys, B. Chevalier, and D. Dudek A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 2014 Sep 12 [E-pub ahead of print]
54. M. Leacche, D.X. Zhao, R. Umakanthan, and J.G. Byrne Do hybrid procedures have proven clinical utility and are they the wave of the future? Hybrid procedures have no proven clinical utility and are not the wave of the future Circulation 125 2012 2504 2510
55. R.E. Harskamp, J.B. Williams, and M.E. Halkos Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease J Thorac Cardiovasc Surg 148 2014 1837 1842
56. M. Leacche, J.G. Byrne, and N.S. Solenkova Comparison of 30-day outcomes of coronary artery bypass grafting surgery versus hybrid coronary revascularization stratified by SYNTAX and EuroSCORE J Thorac Cardiovasc Surg 145 2013 1004 1012
57. S.T. Rab, J.S. Douglas Jr., and E. Lyons Hybrid coronary revascularization for the treatment of left main coronary stenosis: a feasibility study Catheter Cardiovasc Interv 80 2012 238 244
58. J. Shannon, A. Colombo, and O. Alfieri Do hybrid procedures have proven clinical utility and are they the wave of the future? Hybrid procedures have proven clinical utility and are the wave of the future Circulation 125 2012 2492 2503
59. G.M. Fitzgibbon, J.R. Burton, and A.J. Leach Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year Circulation 57 1978 1070 1074
60. M. Gasior, M.O. Zembala, and M. Tajstra Hybrid revascularization for multivessel coronary artery disease JACC Cardiovasc Interv 7 2014 1277 1283
61. N. Bonaros, T. Schachner, and D. Wiedemann Closed chest hybrid coronary revascularization for multivessel disease - current concepts and techniques from a two-center experience Eur J Cardiothorac Surg 40 2011 783 787